EA201100610A1 - Эффективная экспрессия укороченного человеческого белка rnaset2 в e.coli - Google Patents
Эффективная экспрессия укороченного человеческого белка rnaset2 в e.coliInfo
- Publication number
- EA201100610A1 EA201100610A1 EA201100610A EA201100610A EA201100610A1 EA 201100610 A1 EA201100610 A1 EA 201100610A1 EA 201100610 A EA201100610 A EA 201100610A EA 201100610 A EA201100610 A EA 201100610A EA 201100610 A1 EA201100610 A1 EA 201100610A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- rnaset2
- human protein
- redicted
- coli
- effective expression
- Prior art date
Links
- 101000728860 Homo sapiens Ribonuclease T2 Proteins 0.000 title abstract 2
- 102100029683 Ribonuclease T2 Human genes 0.000 title 1
- 241000894006 Bacteria Species 0.000 abstract 1
- 230000001772 anti-angiogenic effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19313408P | 2008-10-30 | 2008-10-30 | |
| PCT/IL2009/001012 WO2010049933A1 (en) | 2008-10-30 | 2009-10-29 | Efficient expression of truncated human rnaset2 in e. coli |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA201100610A1 true EA201100610A1 (ru) | 2011-10-31 |
Family
ID=41694413
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201100610A EA201100610A1 (ru) | 2008-10-30 | 2009-10-29 | Эффективная экспрессия укороченного человеческого белка rnaset2 в e.coli |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20110207667A1 (enExample) |
| EP (1) | EP2346993A1 (enExample) |
| JP (1) | JP2012507278A (enExample) |
| AU (1) | AU2009309277A1 (enExample) |
| CA (1) | CA2739705A1 (enExample) |
| EA (1) | EA201100610A1 (enExample) |
| WO (1) | WO2010049933A1 (enExample) |
| ZA (1) | ZA201102615B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20150009953A (ko) * | 2012-02-29 | 2015-01-27 | 에프. 호프만-라 로슈 아게 | 1→3 해독 프레임 이동의 감소 방법 |
| US11685935B2 (en) * | 2013-05-29 | 2023-06-27 | Cellectis | Compact scaffold of Cas9 in the type II CRISPR system |
| US20160340659A1 (en) | 2014-01-30 | 2016-11-24 | Yissum Research And Development Company Of The Hebrew University Of Jerusalem Ltd. | Actin binding peptides and compositions comprising same for inhibiting angiogenesis and treating medical conditions associated with same |
| JP7082945B2 (ja) * | 2016-03-17 | 2022-06-09 | シーダーズ―シナイ メディカル センター | Ｒｎａｓｅｔ２により炎症性腸疾患を診断する方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001021830A1 (en) * | 1999-09-24 | 2001-03-29 | Ambion, Inc. | Nuclease inhibitor cocktail |
| US6436703B1 (en) * | 2000-03-31 | 2002-08-20 | Hyseq, Inc. | Nucleic acids and polypeptides |
| BRPI0516302A (pt) * | 2004-09-29 | 2008-09-02 | Yissun Res Dev Company Of The | rnase t2 humana recombinante e suas utilizações |
| US7608413B1 (en) * | 2005-03-25 | 2009-10-27 | Celera Corporation | Kidney disease targets and uses thereof |
-
2009
- 2009-10-29 AU AU2009309277A patent/AU2009309277A1/en not_active Abandoned
- 2009-10-29 US US13/126,494 patent/US20110207667A1/en not_active Abandoned
- 2009-10-29 JP JP2011533932A patent/JP2012507278A/ja active Pending
- 2009-10-29 EP EP09760011A patent/EP2346993A1/en not_active Withdrawn
- 2009-10-29 CA CA2739705A patent/CA2739705A1/en not_active Abandoned
- 2009-10-29 WO PCT/IL2009/001012 patent/WO2010049933A1/en not_active Ceased
- 2009-10-29 EA EA201100610A patent/EA201100610A1/ru unknown
-
2011
- 2011-04-08 ZA ZA2011/02615A patent/ZA201102615B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2009309277A1 (en) | 2010-05-06 |
| AU2009309277A8 (en) | 2011-05-12 |
| EP2346993A1 (en) | 2011-07-27 |
| US20110207667A1 (en) | 2011-08-25 |
| WO2010049933A1 (en) | 2010-05-06 |
| CA2739705A1 (en) | 2010-05-06 |
| ZA201102615B (en) | 2012-03-28 |
| JP2012507278A (ja) | 2012-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201171494A1 (ru) | Миметики белка smac | |
| EA201101117A1 (ru) | Ингибиторы дпп-4 для лечения диабета у детей | |
| EA201170242A1 (ru) | Модифицированные бычьи полипептиды g-csf и их применение | |
| EA201101521A1 (ru) | Способы лечения онкологических заболеваний, использующие эпиметаболические переключатели, многоаспектные внутриклеточные молекулы или факторы влияния | |
| EA201500172A1 (ru) | Модифицированные полипептиды фактора х и их применение | |
| EA200870185A1 (ru) | Комбинации ингибиторов ang2 и vegf | |
| DE602008002693D1 (de) | Vakzine-peptid-kombinationen gegen katzenallergie | |
| CR20120266A (es) | Inmunoglobinas con dominio variable dual y usos de las mismas | |
| UA113609C2 (xx) | Антигензв'язуючий білок, який зв'язує людський il-23 | |
| EA201190273A1 (ru) | Комбинация антагониста tnf-альфа и антагониста vegf для применения в лечении или предупреждении заболеваний глаз | |
| UY33826A (es) | Proteínas de unión con dominios trivariables y sus usos | |
| EA201001204A1 (ru) | Методы и композиции, в которых применяют слитые полипептиды klotho-fgf | |
| CY1117655T1 (el) | Παραγοντες οι οποιοι επαγουν αποπτωση για την αντιμετωπιση καρκινου και ανοσολογικων και αυτοανοσων νοσηματων | |
| CY1116728T1 (el) | Παραγοντες οι οποιοι επαγουν αποπτωση για την αντιμετωπιση καρκινου και ανοσολογικων και αυτοανοσων νοσηματων | |
| CL2009001160A1 (es) | Compuestos derivados de heterociclos nitrogenados fusionados y su composicion farmaceutica. | |
| EA201100302A1 (ru) | Лечение диабета у пациентов, для которых лечение метформином является неприемлемым | |
| EA201170212A1 (ru) | Охлаждение и обработка материалов | |
| EA201270566A1 (ru) | Противомикробные соединения и способы их получения и применения | |
| BR112013010857A2 (pt) | imonoglubulinas de duplo domínio variável e usos das mesmas | |
| UA108193C2 (uk) | Апоптозіндукуючий засіб для лікування раку і імунних і аутоімунних захворювань | |
| EA201001372A1 (ru) | Формы рифаксимина и их применение | |
| EP2566492A4 (en) | INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC AND ANTIBODY-BASED COMPOSITIONS RELATED TO GLUTAMYL-PROLYL-ARNT-SYNTHASE SYNTHETIC PROTEIN FRAGMENTS | |
| EA201000735A1 (ru) | Композиции многотипных пептидов hpv и способы лечения или предотвращения папилломавирусной инфекции у человека | |
| EA201001212A8 (ru) | Лечение микробных инфекций | |
| EP2566516A4 (en) | INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF SÉRYLE-ARNT SYNTHÉTASES |